The GAF-tandem domain of phosphodiesterase 5 as a potential drug target.
about
Advances in targeting cyclic nucleotide phosphodiesterasesCyclic nucleotide phosphodiesterases: important signaling modulators and therapeutic targets.Phosphodiesterase 11A (PDE11A), Enriched in Ventral Hippocampus Neurons, is Required for Consolidation of Social but not Nonsocial Memories in Mice.Effect of phosphodiesterase-5 inhibitors on glycemic control in person with type 2 diabetes mellitus: A systematic review and meta-analysis.Targeting PDE10A GAF Domain with Small Molecules: A Way for Allosteric Modulation with Anti-Inflammatory Effects.[Cyclic nucleotide phosphodiesterases: role in the heart and therapeutic perspectives].
P2860
The GAF-tandem domain of phosphodiesterase 5 as a potential drug target.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The GAF-tandem domain of phosphodiesterase 5 as a potential drug target.
@en
The GAF-tandem domain of phosphodiesterase 5 as a potential drug target.
@nl
type
label
The GAF-tandem domain of phosphodiesterase 5 as a potential drug target.
@en
The GAF-tandem domain of phosphodiesterase 5 as a potential drug target.
@nl
prefLabel
The GAF-tandem domain of phosphodiesterase 5 as a potential drug target.
@en
The GAF-tandem domain of phosphodiesterase 5 as a potential drug target.
@nl
P2093
P1476
The GAF-tandem domain of phosphodiesterase 5 as a potential drug target.
@en
P2093
Elvira Gawlitta-Gorka
Gabriele Sorg
Joachim E Schultz
Torsten Dunkern
P304
P356
10.1007/978-3-642-17969-3_6
P577
2011-01-01T00:00:00Z